Category: Pharmaceuticals - Page 2

FDA Label Terms Glossary: Understanding Contraindications, Precautions, and More

  • Apr, 13 2026
  • 11 Comments

Master FDA label terms from contraindications to precautions. A clear guide to understanding prescription drug labeling, safety warnings, and dosing sections.

Read More

How Pharmaceutical Brands Use Formulation Patents on Combinations to Extend Exclusivity

  • Apr, 9 2026
  • 12 Comments

Discover how pharmaceutical companies use formulation and combination patents to extend market exclusivity and delay generic competition through strategic evergreening.

Read More

Mandatory vs Permissive Substitution: How State Laws Shape Generic Drug Access

  • Feb, 27 2026
  • 14 Comments

Mandatory and permissive substitution laws determine whether pharmacists must or can choose to swap brand-name drugs for cheaper generics. These state-level rules affect drug costs, patient adherence, and healthcare savings - with major differences across the U.S.

Read More

When Do Drug Patents Expire? Understanding the 20-Year Term and Real-World Timelines

  • Feb, 23 2026
  • 12 Comments

Drug patents last 20 years from filing, but most drugs lose 5-10 years to clinical trials. Real market exclusivity is often just 7-12 years, with extensions, exclusivity, and patent thickets delaying generics. Learn how expiration really works.

Read More

Dexamethasone vs Prednisone: Potency and Side Effects Compared

  • Feb, 12 2026
  • 9 Comments

Dexamethasone and prednisone are both powerful corticosteroids, but dexamethasone is 9-10 times stronger and lasts longer. Learn when each is preferred, how side effects differ, and why doctors choose one over the other for asthma, cancer, or chronic inflammation.

Read More

How to Prevent Look-Alike Packaging Confusion in the Pharmacy

  • Feb, 7 2026
  • 15 Comments

Look-alike packaging in pharmacies causes thousands of medication errors each year. Learn how physical separation, Tall Man Lettering, and barcode scanning can stop these dangerous mistakes before they happen.

Read More

Pharmacist Role with Biosimilars: Counseling and Substitution

  • Feb, 1 2026
  • 9 Comments

Pharmacists play a critical role in biosimilar adoption by counseling patients, navigating substitution laws, and ensuring safe, cost-effective transitions from reference biologics. Their expertise drives adherence and trust in these complex medications.

Read More

Manufacturing Changes and Generic Approval: What Triggers FDA Re-Evaluation

  • Jan, 27 2026
  • 13 Comments

Learn what manufacturing changes trigger FDA re-evaluation for generic drugs, how the approval process works, and how companies can reduce delays using Quality by Design and new FDA programs.

Read More

Rare Adverse Events with Generics: When and How to Report Side Effects

  • Jan, 17 2026
  • 11 Comments

Learn when and how to report rare side effects from generic medications. Understand FDA guidelines, what counts as serious, and why your report matters for drug safety.

Read More

Diabetes Combination Medications: Generic Options and What You Can Substitute

  • Jan, 16 2026
  • 13 Comments

Discover which diabetes combination medications have affordable generic options, when substitution is safe, and how to save money without risking your blood sugar control. Learn what works, what doesn’t, and what’s coming next.

Read More

Patient Rights: How to Refuse Generic Substitution and Request Brand-Name Drugs

  • Jan, 10 2026
  • 8 Comments

You have the legal right to refuse generic drug substitutions and request brand-name medications. Learn how state laws protect you, when to insist on your prescribed drug, and what to say at the pharmacy counter to avoid risky switches.

Read More

Generic Manufacturer Profitability: Business Models and Sustainability in 2026

  • Jan, 7 2026
  • 9 Comments

Generic drug manufacturers are losing money despite saving billions in healthcare costs. Discover why profitability is collapsing and how companies are adapting with complex generics and contract manufacturing to survive.

Read More